Explaining about possible adverse events may reduce problemsBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7071.1553b (Published 14 December 1996) Cite this as: BMJ 1996;313:1553
- Ron Behrens
- Consultant in tropical and travel medicine Travel Clinic, 4 St Pancras Way, London NW1 0PE
EDITOR,—The adverse events reported by P J Barrett and colleagues in travellers taking mefloquine, who were recruited to the study when seeking telephone advice,1 were subjectively much more severe and disabling than those described in a study from Swiss, Swedish, and American researchers published around the same time2.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial